Authors response to critique of "angiotensin-converting enzyme inhibitors reduce community-acquired pneumonia hospitalization and mortality".

Alexander, Donald P; Nickman, Nancy A; Chhibber, Anindit; Stoddard, Gregory; Biskupiak, Joseph E; Munger, Mark A

Alexander, Donald P; Nickman, Nancy A; Chhibber, Anindit; Stoddard, Gregory; Biskupiak, Joseph E; Munger, Mark A.

Afiliación

Alexander DP; Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA.
Nickman NA; Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA.
Chhibber A; Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA.
Stoddard G; Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
Biskupiak JE; Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA.
Munger MA; Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA.

Pharmacotherapy ; 43(3): 259, 2023 03.

Article en En | MEDLINE | ID: mdl-36915171

Asunto(s)

Inhibidores de la Enzima Convertidora de Angiotensina; Neumonía; Humanos; Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico; Neumonía/tratamiento farmacológico; Hospitalización

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumonía / Inhibidores de la Enzima Convertidora de Angiotensina Límite: Humans Idioma: En Revista: Pharmacotherapy Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google